ESR1 and urinary bladder small cell neuroendocrine carcinoma: SCCB patients with the triple-negative subtype (ER-/PR-/HER2-) seem to have poor prognoses.[16] In this study, most patients were lymph node negative, ER-, PR-, and HER2-.